38 results on '"Amino, Yoshiaki"'
Search Results
2. EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsy
3. Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
4. Advances in the treatment of postoperative recurrence of non–small cell lung cancer and their impact on survival in Asian patients
5. Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
6. Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients
7. Distinction of ALK fusion gene‐ and EGFR mutation‐positive lung cancer with tumor markers
8. Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion
9. Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC
10. Clinical characteristics of patients with KRAS mutation detected by liquid biopsy
11. Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors
12. Real-world outcome analysis of patients with stage IV non-small cell lung cancer treated with tyrosine kinase and immune checkpoint inhibitors
13. A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment
14. Advances in the treatment of postoperative recurrence of non–small cell lung cancer and their impact on survival in Asian patients
15. MO45-3 The efficacy of osimertinib in patients with EGFR-positive non-small cell lung cancer with malignant pleural effusion
16. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with GenexusTM integrated sequencer
17. Minimal Change Disease Associated With Durvalumab
18. Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib
19. Impact of Renin–angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
20. Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2
21. Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice
22. Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases
23. Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment
24. Efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastases.
25. Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-program cell death-1/ligand 1 inhibitors
26. Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer
27. Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-program cell death-1/ligand 1 inhibitors
28. Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer
29. Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC
30. Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice.
31. A case of sinobronchial syndrome progressing to diffuse panbronchiolitis despite low-dose, long-term macrolide therapy
32. A retrospective analysis of the efficacy of immune checkpoint inhibitors (ICIs) to advanced non-small cell cancer (NSCLC) patients (pts) with central nerve system (CNS) metastasis.
33. A case of gingival cancer with pulmonary metastases that developed complete atrioventricular block and ventricular fibrillation as a result of myocardial metastases
34. Bamboo-precocious wood composite beams: theoretical prediction of the bending behaviour
35. Conception and feasibility of bamboo–precocious wood composite beams
36. DEVELOPMENT OF STRUCTURE SYSTEMS IN NAILED OR SCREWED PLANKS(Architectural Planning and Design)
37. DEVELOPMENT OF TIMBER FRAME STRUCTURAL GLAZING SYSTEM(Architectural Planning and Design)
38. Mechanical performance evaluation of bamboo-timber composite beams
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.